Providers evaluate whether Ozempic or similar medications could benefit patients on a case-by-case basis
Drug Development Research
Monitor fasting glucose, HbA1c, lipid panel, B12 levels, thyroid function, liver enzymes, and kidney function
Interesting Finding: Reduced Alcohol Cravings Interestingly, recent research has found that GLP-1 medications may actually reduce alcohol cravings and consumption in some individuals: Studies have shown that both semaglutide (GLP-1 agonist) and tirzepatide (GLP-1/GIP combination) appear to effectively reduce alcohol consumption in individuals with obesity
Buffone, [email protected] These authors have contributed equally to this work Disclaimer All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers
Presented in a sleek pharmaceutical-grade vial with premium green branding, this product is tailored for professional distributors, aesthetic suppliers, wellness businesses, and wholesale buyers seeking high-end peptide solutions with strong market positioning
